![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
|
Lista de Categorias
AlcoolismoAlzheimer E ParkinsonAnalgésicosAnti-InflamatóriosAnti-helmÃnticosAnti-viraisAntialérgicosAntibióticosAnticoncepcionaisAnticonvulsivantesAntidepressivosAntifúngicosArtriteAsmaCancroCirúrgiaColesterolCuidados Da PeleCuidados Para Los OjosDiabetesDisfunção EréctilDiuréticosDoenças CardiovascularesEnxaquecasH I VHipertensão ArterialObesidadeOsteoporosePerturbações MentaisPerturbações NeurológicasRelaxantes MuscularesSaúde FemininaSaúde MasculinaTrato GastrointestinalTrato RespiratórioTrato Urinário 24 May 2012 23:17:33
More Generic Launches for Mylan Moneycontrol.com More Generic Launches for Mylan Zacks.com Just a few days ago, Mylan Inc received final approval from the FDA to launch its generic versions of Plavix (clopidogrel), 75 mg and 300 mg. Plavix is sold by Bristol-Myers Squibb Co. (BMY - Analyst Report) and Sanofi (SNY - Analyst Report) and is ... More Generic Launches for Mylan - Analyst Blog24 May 2012 18:05:13
First bedside DNA test to be introduced in Middle EastFirst bedside DNA test to be introduced in Middle East San Francisco Chronicle (press release) (2) Genetic carriers who receive Plavix  (clopidogrel) following a cardiac stent have a 42 percent higher risk of death, stroke, or heart attack in the first year compared to non-carriers.(3) Following this stenting procedure, patients are typically ...
24 May 2012 13:00:06
TEXT-S&P summary: SanofiTEXT-S&P summary: Sanofi Reuters This reflects our base-case view that the pending patent erosion on key drugs Plavix , Lovenox, Taxotere, and Approvel will be more than offset by the growth of already existing products such as Lantus and the recovering Genzyme products, ...
23 May 2012 12:06:00
Generics in Cardiovascular Diseases Market to 2018 – Loss of Lipitor Market ...Generics in Cardiovascular Diseases Market to 2018 â Loss of Lipitor Market ... NEWS.GNOM.ES GBI Research, the leading business intelligence provider, has released its latest research â Generics in Cardiovascular Diseases Market to 2018 â Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic ... Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market ...
22 May 2012 14:31:20
Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as ...Accumetrics Sees Significantly Increased Interest in VerifyNow P2Y12 Test as ... MarketWatch (press release) Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, P2Y12 inhibitors (eg prasugrel (Effient(R)) and clopidogrel ( Plavix (R))), and GP IIb IIIa inhibitors (eg ReoPro(R) and Integrilin(R)), the VerifyNow System provides ...
22 May 2012 12:10:55
HealthWarehouse.com Offers Consumers the Lowest Price on Generic Plavix® Medical Daily HealthWarehouse.com Offers Consumers the Lowest Price on Generic Plavix  MarketWatch (press release) CINCINNATI, May 22, 2012 PRNewswire via COMTEX -- HealthWarehouse.com, Inc. (OTN:HEWA) a leading VIPPS -accredited online retail mail-order pharmacy is now providing consumers with the lowest price option available for generic Plavix  in the United ... FDA Approves Generic Plavix Generic Launches Continue at Mylan - Analyst Blog Newly Approved Generic Blood Thinner Saves Costs18 May 2012 15:58:07
Plavix goes generic; drowning is a leading killer of kids CBS News Plavix goes generic; drowning is a leading killer of kids USA TODAY By Kim Painter, USA TODAY Generic Plavix : If you take the blood thinning drug Plavix , the cost of your medicine just dropped dramatically, from about $200 to $40 or less each month. That's because the Food and Drug Administration just approved multiple ... FDA approves Plavix as a generic FDA Approves Generic Versions of Plavix FDA approves 7 companies to sell generic Plavix - -16 May 2012 18:34:44
Plavix Set to Lose Patent Protection Business Standard Plavix Set to Lose Patent Protection New York Times For more than a decade, cardiologists treating patients who have had a heart attack have routinely scribbled one drug onto their prescription pads: clopidogrel bisulfate, better known as Plavix . â It's a mainstay,â said Dr. Steven Nissen, ... Clot-fighting drug Plavix loses patent protection After a Sentence to Write Sentences, Dr. Bodnar Ends a Legal Chapter Dr Reddy's may launch low-cost copy of Plavix in US - |
|
Choose Your language:
Pesquisa no site:
Testemunhos
Bom dia:
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Mais vendidos|Política|Questões Mais Frequentes|Testemunhos|Contacte-nos|Sitemap |
|
|
|
|
| |